Levothyroxine Other names: Synthetic T4 Levothyroxine sodium 3,5,3',5'-tetraiodo-L-thyronine L-thyroxine

Therapeutic indications

Levothyroxine is indicated for:

Congenital hypothyroidism

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypothyroidism

Population group: only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acquired hypothyroidism

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Juvenile myxedema

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Levothyroxine is contraindicated in the following cases:

Thyrotoxicosis

Adrenal gland disorder, adrenal insufficiency